Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
暂无分享,去创建一个
C Warlow | R Peto | R. Collins | P. Sandercock | R. Peto | C. Warlow | C. Counsell | P. Sandercock | L. Liu | C Counsell | Z M Chen | P Sandercock | H C Pan | R Collins | L S Liu | J X Xie | H. Pan | Z. Chen | Zhengming Chen | J. Xie | Lisheng Liu | C. Warlow | J. X. Xie | Z. Chen | JingXian Xie
[1] P. Sandercock,et al. Antiplatelet therapy in acute cerebral ischaemia. , 1999, Stroke.
[2] J. Colwell,et al. Aspirin and risk of hemorrhagic stroke. , 1999, JAMA.
[3] M. Bednar,et al. Antiplatelet therapy in acute cerebral ischemia. , 1999, Stroke.
[4] M. Kendall,et al. Clinical trials in stroke , 1999, The Lancet.
[5] C. Sudlow,et al. Immediate aspirin for suspected ischaemic stroke , 1999, The Lancet.
[6] Y. Tokuda,et al. Aspirin and risk of hemorrhagic stroke. , 1999, JAMA.
[7] P. Whelton,et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.
[8] Michael D Hill,et al. Stroke treatment: time is brain , 1998, The Lancet.
[9] Management soon after a stroke , 1998, Drug and therapeutics bulletin.
[10] D. Barer. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[11] G. Lip,et al. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[12] L. Tan. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[13] T. Strandberg,et al. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[14] P. Sandercock,et al. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[15] K. Lees,et al. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[16] A. Członkowska,et al. Interpretation of IST and CAST stroke trials , 1997, The Lancet.
[17] Zheng-Ming Chen,et al. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.
[18] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[19] M. Bousser. Aspirin or heparin immediately after a stroke? , 1997, The Lancet.
[20] A. Watson,et al. Lipid metabolism and APC: implications for colorectal cancer prevention , 1997, The Lancet.
[21] C. Gropper. Windows of the sole? Robert Baran Rodney PR Dawber , 1997, The Lancet.
[22] A. Cohen. Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial. , 1997, Lancet.
[23] L. Munari,et al. RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE , 1995 .
[24] P. Toutouzas,et al. Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease , 1995, The Lancet.
[25] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[26] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.
[27] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[28] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[29] B. Schoenberg,et al. Cerebrovascular disease in the People's Republic of China , 1985, Neurology.
[30] E. Veys,et al. Letter: HL-A and infective sacroileitis. , 1974, Lancet.